$9.70
-0.29-2.9%
Last update: Oct 23, 7:42 PM
Novavax Inc (NVAX) Stock Price, Quote, News & History
NVAXNASDAQ
Shah Capital sells 2.87M Novavax (NVAX) shares for $32.6M, ends activist campaign, and shifts to a family office structure.
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Other companies in Novavax’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Novavax has a consensus price target of $13.08.
The stock price for Novavax (NASDAQ: NVAX) is $9.7894 last updated October 23, 2026 at 7:42 PM EDT.
There are no upcoming dividends for Novavax.
Novavax does not have any upcoming earnings scheduled.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish...
